By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Avelas Biosciences 

11099 N. Torrey Pines Road
Suite 290
La Jolla  California  92037  U.S.A.
Phone: n/a Fax: n/a



Company News
Avelas Biosciences Announces AVB-620 Presentation At 2016 San Antonio Breast Cancer Symposium 12/1/2016 8:45:18 AM
Avelas Biosciences Completes Patient Enrollment For AVB-620 Phase 1b Clinical Trial 9/8/2016 8:04:18 AM
San Diego's Avelas Biosciences Scores $20 Million for Cancer Detecting Agent 8/18/2016 6:00:45 AM
Avelas Biosciences Announces Positive Interim Phase 1b Results And Advances To Dose Expansion Stage 5/9/2016 6:35:04 AM
Avelas Biosciences To Present At The Needham & Company 15th Annual Healthcare Conference 4/6/2016 7:18:16 AM
Avelas Biosciences To Present At 28th Annual Roth Conference 3/8/2016 7:46:17 AM
Avelas Biosciences Release: Clinical Trial Of Cancer Illuminator To Increase Surgical Accuracy For Breast Cancer Starts At University of California, San Francisco (UCSF) 10/29/2015 8:09:20 AM
Avelas Biosciences Initiates Phase 1b Trial Of AVB-620 In Breast Cancer Patients 4/16/2015 6:26:43 AM
San Diego's Avelas Biosciences Snags $7.4 Million 9/10/2014 7:34:39 AM
Avelas Biosciences Lands $6.85 Million Series B Financing To Advance Real-Time Cancer Visualization Technology To Clinical Proof-Of-Concept 1/9/2014 6:51:17 AM